Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| Upstream (Parents) |
|---|
| (<<) HIST1H3H → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) HIST2H2BE → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) BTNL8 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) TMEM231 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) LOC100133811///LOC100133661///ECRP///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) PHLDA2 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) NUS1P3 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) SCRN1 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| (<<) EGFL7 → HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI |
| Downstream (Children) |
|---|
| HIST1H2AH///HIST1H2AG///HIST1H2AM///HIST1H2AL///HIST1H2AJ///HIST1H2AK///HIST1H2AI → NUP54 (>>) |
